2024-05-09 11:00:13 ET
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)
Q1 2024 Earnings Call
May 09, 2024 , 8:30 a.m. ET
Operator
For further details see:
CorMedix (CRMD) Q1 2024 Earnings Call Transcript2024-05-09 11:00:13 ET
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)
Q1 2024 Earnings Call
May 09, 2024 , 8:30 a.m. ET
Operator
For further details see:
CorMedix (CRMD) Q1 2024 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has commenced commercialization of DefenCath ® (tauroli...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...
2024-06-07 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...